New York A 7409: Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
A07409 Summary:

BILL NOA07409 

&nbsp

SAME ASNo Same As

&nbsp

SPONSORBrown K

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Amd §3309, Pub Health L; amd §§19.09, 36.01 & 25.18, Ment Hyg L; amd §6908, Ed L; amd §2617, Ins L

&nbsp

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.

Go to top A07409 Actions:

BILL NOA07409 

&nbsp

03/25/2025referred to health

01/07/2026referred to health

Go to topA07409 Committee&nbspVotes:

Go to topA07409 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topA07409 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 7409

 2025-2026 Regular Sessions

 IN ASSEMBLY

 March 25, 2025
 ___________

 Introduced by M. of A. K. BROWN -- read once and referred to the Commit-
 tee on Health

 AN ACT to amend the public health law, the mental hygiene law, the
 education law and the insurance law, in relation to including all FDA
 approved forms and doses of Naloxone as opioid antagonists in the
 state definition of opioid antagonists

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. Subparagraph (i) of paragraph (a) of subdivision 3 of
 2 section 3309 of the public health law, as amended by chapter 42 of the
 3 laws of 2014, is amended and a new subdivision 10 is added to read as
 4 follows:
 5 (i) "Opioid antagonist" means a drug approved by the Food and Drug
 6 Administration that, when administered, negates or neutralizes in whole
 7 or in part the pharmacological effects of an opioid in the body. "Opioid
 8 antagonist" shall be limited to [naloxone and other medications approved
 9 by the department for such purpose] all forms and doses of Naloxone
 10 approved by the Food and Drug Administration. The department shall make
 11 available all forms of Naloxone for such purpose in any formulation or
 12 dosage approved by the Food and Drug Administration.
 13 10. Any purchase of, distribution of, or authorization to prescribe an
 14 opioid antagonist pursuant to this section shall allow for choice of any
 15 formulation or dosage approved by the Food and Drug Administration and
 16 made available by the department.
 17 § 2. Subparagraph (ii) of paragraph 1 of subdivision (l) of section
 18 19.09 of the mental hygiene law, as added by chapter 434 of the laws of
 19 2021, is amended and a new paragraph 4 is added to read as follows:
 20 (ii) "Opioid antagonist" means a federal food and drug administra-
 21 tion-approved drug that, when administered, negates or neutralizes in
 22 whole or in part the pharmacological effects of an opioid in the body.
 23 The opioid antagonist shall be limited to [naloxone or other medications

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD10307-01-5

 A. 7409 2

 1 approved by the department of health for this purpose] all forms and
 2 doses of Naloxone approved by the Food and Drug Administration. The
 3 department of health shall make available all forms of Naloxone for such
 4 purpose in any formulation or dosage approved by the Food and Drug
 5 Administration.
 6 (4) Any purchase of, distribution of, or authorization to prescribe an
 7 opioid antagonist pursuant to this subdivision shall allow for choice of
 8 any formulation or dosage approved by the Food and Drug Administration
 9 and made available by the department of health.
 10 § 3. Paragraph a of subdivision 2 of section 6908 of the education
 11 law, as added by chapter 471 of the laws of 2016, is amended to read as
 12 follows:
 13 a. specify the advanced tasks that may be performed by advanced home
 14 health aides pursuant to this subdivision. Such tasks shall include the
 15 administration of medications which are routine and prefilled or other-
 16 wise packaged in a manner that promotes relative ease of administration,
 17 provided that administration of medications by injection, sterile proce-
 18 dures, and central line maintenance shall be prohibited. Provided,
 19 however, such prohibition shall not apply to injec